Skip to main content

Table 3 Comparison of change in ETDRS from baseline 6 months of treatment in the EPIC trial

From: Prospective clinical trial of Intravitreal aflibercept treatment for PolypoIdal choroidal vasculopathy with hemorrhage or exudation (EPIC study): 6 month results

Change in ETDRS letters

Treatment naïve (%)

Previously treated (%)

Total

Improved ≥ 5 Letters

3 (30)

3 (27)

6

Unchanged < 5 Letters Change

6 (60)

7 (64)

13

Decreased ≥ 5 Letters

1 (10)

1 (9)

2

Increase ≥ 15 Letters

0

0

0

Decrease ≥ 15 Letters

0

1 (9)

1

  1. ETDRS Early Treatment Diabetic Retinopathy Study